NEET PG Pharmacology: High-Yield Strategy and Must-Know Drugs

Pharmacology is one of the highest-scoring subjects in NEET PG when approached strategically. Across recent examinations, pharmacology has consistently contributed 15-25 questions — a significant block of marks that can be secured with focused, mechanism-based preparation. Unlike anatomy or biochemistry, where the breadth of content can feel overwhelming, pharmacology rewards systematic study of drug classes, their mechanisms, and their clinical applications. This guide provides a structured strategy to maximise your pharmacology score efficiently.

Why Pharmacology Is Your Best Investment

Pharmacology has three characteristics that make it uniquely high-yield for NEET PG:

1. Predictable question patterns — the same drug classes and principles are tested repeatedly, with questions varying only in clinical context

2. Cross-subject integration — pharmacology questions overlap heavily with medicine, surgery, obstetrics, paediatrics, and PSM, meaning your pharmacology revision simultaneously strengthens other subjects

3. Mechanism-based reasoning — understanding one drug's mechanism often lets you predict the answer for related drugs, even if you have not specifically revised that particular agent

The most efficient approach is not to memorise every drug in Tripathi or Katzung, but to master the core drug classes deeply and learn to reason from mechanisms ^[1][2].

Top Drug Classes by Question Frequency

Based on analysis of NEET PG question patterns, the following drug classes appear most frequently. If you are short on time, prioritise these areas ruthlessly.

1. Antimicrobials (4-6 questions per exam)

Antibiotics, antifungals, antivirals, and antimalarials collectively form the single largest pharmacology question pool.

• Beta-lactams — mechanism (transpeptidase inhibition, cell wall synthesis), spectrum differences between penicillins, cephalosporin generations (first through fifth), carbapenems, cross-reactivity in penicillin allergy
• Aminoglycosides — mechanism (irreversible binding to 30S ribosomal subunit), concentration-dependent killing, post-antibiotic effect, ototoxicity and nephrotoxicity, once-daily dosing rationale
• Fluoroquinolones — mechanism (DNA gyrase and topoisomerase IV inhibition), tendon rupture risk, QT prolongation, contraindication in children (cartilage damage)
• Antitubercular drugs — RIPE regimen (rifampicin, isoniazid, pyrazinamide, ethambutol), individual side effects (rifampicin: hepatotoxicity, enzyme induction, orange secretions; isoniazid: peripheral neuropathy, hepatotoxicity, lupus-like syndrome, pyridoxine prophylaxis; ethambutol: optic neuritis; pyrazinamide: hyperuricaemia, hepatotoxicity)
• Antifungals — amphotericin B (ergosterol binding, nephrotoxicity, infusion reactions), azoles (CYP-mediated ergosterol synthesis inhibition), echinocandins (glucan synthesis inhibition, for invasive candidiasis)

2. Autonomic Pharmacology (3-5 questions per exam)

The autonomic nervous system is a favourite NEET PG topic because it integrates pharmacology with physiology.

• Cholinergic drugs — muscarinic vs nicotinic receptor subtypes, direct agonists (pilocarpine for glaucoma, bethanechol for urinary retention), anticholinesterases (physostigmine, neostigmine, pyridostigmine — their clinical uses and differences), organophosphate poisoning (atropine plus pralidoxime)
• Adrenergic drugs — receptor subtypes (alpha-1, alpha-2, beta-1, beta-2, beta-3) and their tissue distribution, adrenaline (non-selective), noradrenaline (alpha-1 and beta-1), isoprenaline (non-selective beta), dobutamine (beta-1 selective), phenylephrine (alpha-1 selective)
• Adrenergic antagonists — propranolol (non-selective beta blocker), atenolol/metoprolol (beta-1 selective), carvedilol (alpha and beta blocker), prazosin (alpha-1 blocker for phaeochromocytoma and BPH), phentolamine (non-selective alpha blocker)

3. Cardiovascular Pharmacology (3-5 questions per exam)

• Antihypertensives — mechanism and side effects of each class: ACE inhibitors (dry cough, hyperkalaemia, angioedema, teratogenic), ARBs, calcium channel blockers (dihydropyridines vs non-dihydropyridines), thiazides (hyponatraemia, hypokalaemia, hyperuricaemia, hypercalcaemia)
• Antiarrhythmics — Vaughan-Williams classification: Class I (sodium channel blockers — Ia: quinidine, procainamide; Ib: lidocaine, phenytoin; Ic: flecainide), Class II (beta blockers), Class III (amiodarone, sotalol), Class IV (verapamil, diltiazem). Amiodarone side effects are tested almost every year
• Heart failure drugs — ACE inhibitors, beta blockers (carvedilol, bisoprolol, metoprolol), sacubitril/valsartan (ARNI), spironolactone (MRA), digoxin (mechanism: Na+/K+ ATPase inhibition, toxicity signs, hypokalaemia increases toxicity)
• Antianginals — nitrates (mechanism: NO release, venodilation, tolerance phenomenon), beta blockers, calcium channel blockers, ranolazine, nicorandil (K+ channel opener)

4. CNS Pharmacology (3-4 questions per exam)

• Antiepileptics — drug of choice by seizure type: sodium valproate (generalised), carbamazepine (focal), ethosuximide (absence), levetiracetam (broad spectrum). Valproate teratogenicity (neural tube defects), carbamazepine (enzyme inducer, SIADH, Stevens-Johnson syndrome), phenytoin (zero-order kinetics, gingival hyperplasia, hirsutism, megaloblastic anaemia)
• Antidepressants — SSRIs (mechanism, serotonin syndrome features, safe in overdose), TCAs (anticholinergic effects, cardiac toxicity in overdose, sodium bicarbonate for TCA poisoning), MAOIs (tyramine reaction — "cheese effect")
• Antipsychotics — typical (haloperidol: D2 blockade, EPS, NMS) vs atypical (olanzapine: metabolic syndrome; clozapine: agranulocytosis, seizures, monitoring requirements), NMS management (dantrolene, bromocriptine)
• General anaesthetics — minimum alveolar concentration (MAC), blood:gas partition coefficient (low = faster onset), thiopentone (redistribution), propofol, ketamine (dissociative, NMDA antagonist, bronchodilator, raises ICP)

The Mechanism-Based Learning Approach

Rather than memorising isolated facts, build your pharmacology understanding on mechanisms. This approach has three advantages:

1. One mechanism explains multiple facts — knowing that rifampicin is a potent CYP450 inducer explains why it reduces the efficacy of oral contraceptives, warfarin, cyclosporine, and protease inhibitors simultaneously

2. Side effects become predictable — anticholinergic drugs cause dry mouth, constipation, urinary retention, tachycardia, and blurred vision because these are all consequences of muscarinic blockade

3. Drug of choice becomes logical — metformin is first-line in type 2 diabetes because it reduces hepatic glucose output without causing hypoglycaemia or weight gain, not simply because guidelines say so

How to apply this in practice

For every drug class, build a mental framework: mechanism of action leads to therapeutic effect leads to side effects leads to contraindications leads to drug interactions. This chain is internally consistent and far more memorable than disconnected facts.

Must-Know Side Effects: The Exam Favourite

Side effect questions are among the most commonly tested pharmacology items in NEET PG. These specific associations appear repeatedly:

• Methotrexate — pancytopenia (folate antagonism), hepatic fibrosis, pneumonitis, teratogenicity; rescued with folinic acid (leucovorin)
• Amiodarone — thyroid dysfunction (both hyper and hypo, due to iodine content), pulmonary fibrosis, corneal microdeposits, slate-grey skin discolouration, hepatotoxicity, peripheral neuropathy
• Chloroquine — retinopathy (bull's eye maculopathy), ototoxicity, cardiomyopathy with prolonged use
• Cyclophosphamide — haemorrhagic cystitis (prevented with mesna), myelosuppression, secondary malignancy, infertility
• Cisplatin — nephrotoxicity (prevented with saline hydration), ototoxicity, peripheral neuropathy, severe emesis (requires 5-HT3 antagonist)
• Lithium — nephrogenic diabetes insipidus, hypothyroidism, tremor, teratogenicity (Ebstein's anomaly), narrow therapeutic index
• Sodium valproate — neural tube defects (teratogenic), hepatotoxicity, pancreatitis, weight gain, tremor, alopecia, thrombocytopenia

Drug of Choice: The Quick-Fire Round

NEET PG frequently tests "drug of choice" in a direct format. These are the most commonly asked:

• Acute anaphylaxis — intramuscular adrenaline
• Organophosphate poisoning — atropine (muscarinic blockade) plus pralidoxime (AChE reactivator)
• Myasthenia gravis — pyridostigmine (long-acting anticholinesterase); thymectomy for definitive management
• Absence seizures — ethosuximide (or sodium valproate if co-existing generalised seizures)
• Status epilepticus — IV lorazepam or diazepam (first-line), then phenytoin/fosphenytoin
• Acute gout — NSAIDs or colchicine (not allopurinol, which is prophylactic)
• Migraine prophylaxis — propranolol (first-line), topiramate, amitriptyline
• MRSA skin infection — vancomycin (IV) or linezolid
• Pseudomembranous colitis (C. difficile) — oral vancomycin (not IV, as vancomycin does not reach the gut lumen when given IV) or fidaxomicin
• Benign prostatic hyperplasia — tamsulosin (alpha-1A blocker) for symptomatic relief; finasteride (5-alpha reductase inhibitor) for large prostates
• Rheumatoid arthritis — methotrexate (first-line DMARD)
• Diabetic nephropathy — ACE inhibitor or ARB (renoprotective via efferent arteriolar dilation)

Pharmacokinetics: The Conceptual Questions

NEET PG includes 2-3 questions testing pharmacokinetic principles. These are conceptual, not calculation-heavy:

• Zero-order kinetics — constant amount eliminated per unit time regardless of concentration (examples: phenytoin at therapeutic doses, ethanol, aspirin in overdose). The clinical implication: small dose increases cause disproportionate rises in plasma levels
• First-order kinetics — constant fraction eliminated per unit time (most drugs). Half-life is constant and independent of dose
• Bioavailability — fraction of administered dose reaching systemic circulation unchanged. IV bioavailability is 100% by definition. First-pass metabolism reduces oral bioavailability (morphine, propranolol, lidocaine)
• Volume of distribution (Vd) — large Vd indicates extensive tissue binding (chloroquine, digoxin); small Vd indicates plasma protein binding (warfarin). Not dialysable if Vd is very large
• Therapeutic drug monitoring — drugs requiring monitoring: lithium, phenytoin, digoxin, aminoglycosides, vancomycin, theophylline, cyclosporine. Know why each requires monitoring

Recently Added and Emerging Drugs

NEET PG increasingly includes questions on newer agents. Be aware of:

• Sacubitril/valsartan — neprilysin inhibitor/ARB combination for heart failure with reduced ejection fraction; superior to enalapril alone (PARADIGM-HF trial)
• SGLT2 inhibitors — empagliflozin, dapagliflozin, canagliflozin; mechanism (inhibit sodium-glucose co-transporter 2 in proximal tubule); benefits in heart failure and CKD independent of diabetes; side effects (genital mycotic infections, euglycaemic DKA, Fournier's gangrene)
• GLP-1 receptor agonists — semaglutide, liraglutide; weight loss and cardiovascular benefit; pancreatitis risk, contraindicated in medullary thyroid carcinoma (C-cell tumours in animal studies)
• Immune checkpoint inhibitors — pembrolizumab, nivolumab (PD-1 inhibitors); ipilimumab (CTLA-4 inhibitor); immune-related adverse events (colitis, hepatitis, pneumonitis, thyroiditis)
• DOACs — dabigatran (direct thrombin inhibitor, idarucizumab reversal), rivaroxaban/apixaban/edoxaban (factor Xa inhibitors, andexanet alfa reversal)

Integration with Pathology and Medicine

The highest-value pharmacology revision integrates with pathology and medicine. For NEET PG, think in clinical chains:

• Pathology link — tuberculosis pathology (caseating granuloma, Langhans giant cells) directly leads to RIPE regimen pharmacology
• Medicine link — understanding diabetic complications (retinopathy, nephropathy, neuropathy) explains why ACE inhibitors, statins, and tight glycaemic control are the management pillars
• Surgery link — anaesthesia pharmacology (succinylcholine causing hyperkalaemia in burns, malignant hyperthermia with dantrolene treatment) integrates surgical and pharmacological knowledge

This cross-subject approach means your pharmacology revision simultaneously prepares you for medicine, surgery, and other clinical subject questions.

Building Your Pharmacology Revision Plan

1. Week 1-2: Autonomic pharmacology and general pharmacology principles (pharmacokinetics, pharmacodynamics, drug interactions) — this builds the foundation for everything else

2. Week 3-4: Antimicrobials and chemotherapy — the largest question pool

3. Week 5-6: Cardiovascular, CNS, and endocrine pharmacology

4. Week 7-8: Autacoids (histamine, prostaglandins, 5-HT), GI pharmacology, respiratory pharmacology, and recently added drugs

5. Throughout: Practise MCQs after every topic. Review "drug of choice" lists weekly

How MedNext Academy Supports Your NEET PG Pharmacology

MedNext Academy's pharmacology module provides mechanism-based study notes mapped to the NEET PG syllabus, with integrated MCQs testing each drug class at both recall and application levels. The platform tracks your performance by topic, identifying weak drug classes for targeted revision. Every question includes a detailed explanation linking the pharmacological mechanism to the clinical scenario.

References

• Tripathi KD. Essentials of Medical Pharmacology. 8th Edition, 2019.
• Katzung BG. Basic & Clinical Pharmacology. 15th Edition, 2021.